This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Janet M. Torpy, MD

JAMA. 2002;287:1638-1639.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Las Vegas, Nev—Medical therapy for people with heart disease improves as clinicians put into practice the results of data from clinical trials, experts said at the 40th Anniversary Symposium on Critical Care, Trauma, and Emergency Medicine, presented here by the University of Southern California School of Medicine.

"Myocardial infarction (MI) is still the big killer," said Joseph E. Parrillo, MD, professor of medicine and director of cardiovascular disease and critical care at Robert Wood Johnson Medical School, Camden, NJ. Each year in the United States, 1.5 million MIs occur, with a 10% mortality rate in hospitalized patients, said Parrillo, and a 30% to 35% overall MI mortality due to sudden, out-of-hospital deaths. He said that although modern MI care is based on evidence and results from large trials, "patients in clinical trials are highly selected—not like those coming into your hospital." Randomized controlled trials are . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?